MNX1 and acute myeloid leukemia: This group of adult MNX1-rearranged patients had a gene expression signature that is similar to t(7;12) pediatric AML (59), suggesting that therapeutic strategies targeting MNX1 could be jointly investigated for both pediatric and adult MNX1-rearranged AML cases.